Technical Analysis for CGIX - Cancer Genetics, Inc.

Grade Last Price % Change Price Change
C 6.1 -2.09% -0.13
CGIX closed down 4.3 percent on Monday, March 1, 2021, on 59 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up
Historical CGIX trend table...

Date Alert Name Type % Chg
NR7 Range Contraction -2.09%
Wide Bands Range Expansion -2.09%
Oversold Stochastic Weakness -2.09%
Inside Day Range Contraction -6.30%
Wide Bands Range Expansion -6.30%
Up 3 Days in a Row Strength -6.30%
Oversold Stochastic Weakness -6.30%
20 DMA Support Bullish -4.98%
Stochastic Buy Signal Bullish -4.98%
Wide Bands Range Expansion -4.98%
Older End-of-Day Signals for CGIX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 2 hours ago
Down 2 % about 2 hours ago
Down 1% about 2 hours ago
Fell Below Previous Day's Low about 2 hours ago
10 DMA Support about 21 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Cancer Genetics, Inc. Description

Cancer Genetics, Inc., an early-stage diagnostics company, focuses on the development and commercialization of proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to treatment of cancer. The company offers a range of services in various areas, including microarray based testing, a proprietary microarray test for the detection of chromosomal abnormalities observed in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma and Diffuse Large B-cell Lymphoma; molecular testing to analyze DNA and RNA to follow progression of disease and response to therapy at the genetic level; cytogenetics testing, a series of methods for analyzing human chromosomes to identify malignancy; fish testing, an analysis of abnormalities at the chromosomal and gene levels; flow cytometry testing, an immuno pheno - type analysis of specific markers inside cells; histology testing, a microscopic examination of stained tissue sections; cytology testing, a non-gynecological fluid preparation for microscopic evaluations by a pathologist; and IHC testing, an analysis of the distribution of tumor antigens in specific cell and tissue types. It offers DNA-based cancer diagnostics and services medical institutions. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also provides a range of non-proprietary oncology-focused tests and laboratory services that offer critical genomic information to healthcare professionals, as well as biopharma and biotech. The company was founded in 1999 and is headquartered in Rutherford, New Jersey.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Biology Disease Treatment Of Cancer Cancers Lymphoma Genetics Molecular Biology Tumor Laboratory Services Anatomical Pathology Chronic Lymphocytic Leukemia Lymphocytic Leukemia Pathology Flow Cytometry HPV Human Papillomavirus Infection Cytogenetics Dna Based Cancer DNA Chip Fluorescence In Situ Hybridization Tumor Antigen

Is CGIX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.5
52 Week Low 1.92
Average Volume 2,323,170
200-Day Moving Average 3.59
50-Day Moving Average 4.25
20-Day Moving Average 5.66
10-Day Moving Average 6.08
Average True Range 1.14
ADX 55.27
+DI 49.99
-DI 17.10
Chandelier Exit (Long, 3 ATRs ) 14.08
Chandelier Exit (Short, 3 ATRs ) 6.93
Upper Bollinger Band 8.26
Lower Bollinger Band 3.06
Percent B (%b) 0.61
BandWidth 91.77
MACD Line 0.57
MACD Signal Line 0.63
MACD Histogram -0.0593
Fundamentals Value
Market Cap 25.39 Million
Num Shares 4.07 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -12.10
Price-to-Sales 0.84
Price-to-Book 2.07
PEG Ratio -0.08
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.13
Resistance 3 (R3) 7.17 6.91 6.98
Resistance 2 (R2) 6.91 6.68 6.89 6.93
Resistance 1 (R1) 6.57 6.54 6.44 6.53 6.88
Pivot Point 6.31 6.31 6.25 6.29 6.31
Support 1 (S1) 5.97 6.08 5.84 5.93 5.58
Support 2 (S2) 5.71 5.94 5.69 5.53
Support 3 (S3) 5.37 5.71 5.48
Support 4 (S4) 5.33